U.S. Tech Hardware Stock News

Why Veeva Systems (VEEV) Is Back on Investors’ Radar Veeva Systems (VEEV) is drawing fresh attention as its March 4 earnings date approaches, with traders reacting to recent share moves, analyst confidence in projected growth, and new client adoption headlines. See our latest analysis for Veeva Systems. Despite pockets of buying interest around recent client wins such as BioDlink’s Veeva QMS go live, momentum has been weak, with a 30 day share price return of a 24.73% decline and a 1 year...

Why Centuri’s latest commercial wins matter for stock watchers Centuri Holdings (CTRI) has secured more than US$300 million in new commercial awards, pushing year to date bookings past US$1b and underscoring continued demand for its utility infrastructure services. The awards are tied to gas distribution modernization across the Midwest and Northeast, including a new geographic area with a longstanding utility client, as well as new industrial work for an electric generation and transmission...

If you are wondering whether JPMorgan Chase is still good value at around US$302.64 per share, this article walks through what the current price might be implying and how that stacks up against several valuation checks. The stock has had mixed recent returns, with a 2.4% decline over the last 7 days and a 2.7% decline over the last 30 days. The 1 year return sits at 11.8% and the 3 year and 5 year returns are 129.1% and 136.0% respectively. Recent headlines around JPMorgan Chase have focused...

Primerica (PRI) has capped FY 2025 with fourth quarter revenue of US$853.7 million, basic EPS of US$6.16 and net income of US$197.0 million, alongside a combined ratio of 66.3% that gives an immediate read on underwriting profitability. The company has seen quarterly revenue move from US$803.4 million and basic EPS of US$4.99 in Q4 2024 to US$853.7 million and US$6.16 in Q4 2025. Trailing 12 month revenue sits at about US$3.3 billion and EPS at US$23.02, setting the stage for investors to...

IREN (NasdaqGS:IREN) has signed a $9.7b AI infrastructure contract with Microsoft, centered on supplying capacity for advanced computing. The company is expanding its data center footprint, including a planned 1.6 GW AI campus in Oklahoma and a total of 4.5 GW secured power by 2028. IREN is set to be added to the MSCI USA Index, reflecting increased attention from institutional investors. The company is moving its core focus from bitcoin mining toward large scale AI infrastructure...

Global Ship Lease (GSL) has declared a quarterly dividend of $0.625 per Class A common share for the fourth quarter of 2025, payable on March 6, 2026, to shareholders of record on February 24. See our latest analysis for Global Ship Lease. The latest dividend decision lands after a strong period for shareholders, with a 1 year total shareholder return of 78.63% and a 3 year total shareholder return of 142.17%. The share price near US$37.19 has also seen positive shorter term momentum,...

Voya Financial, Inc. has released its fourth-quarter and full-year 2025 results, reporting revenue of US$2,111 million and net income of US$140 million for the quarter, and full-year revenue of US$8,189 million with net income of US$654 million, alongside plans for a US$150 million share repurchase in early 2026. The company is highlighting momentum in its Retirement and Investment Management businesses, integration benefits from the OneAmerica acquisition, and the launch of a new retirement...

If you are wondering whether D.R. Horton is fairly priced or offering value at its current share price, this article walks through the key numbers to help you frame that question clearly. The stock recently closed at US$164.59, with returns of 4.1% over 7 days, 2.3% over 30 days, 12.9% year to date, 28.8% over 1 year, 74.5% over 3 years and 121.2% over 5 years. These figures may influence how investors think about both growth potential and risk. Recent coverage around D.R. Horton has focused...

Similarweb (SMWB) has drawn fresh attention after launching AI Studio, an enterprise AI intelligence platform that lets clients query its extensive digital data through conversational research, deep reports, and auto generated dashboards for business decision support. See our latest analysis for Similarweb. The AI Studio launch and Bloomberg Terminal integration arrive during a weak patch for the stock, with Similarweb’s 30 day share price return of 39.16% and year to date share price return...

Matic recently announced a partnership with nCino to embed its home insurance marketplace directly into nCino’s mortgage point of sale platform, allowing borrowers to shop for coverage within the digital loan process. This integration extends nCino’s mortgage workflow into adjacent insurance services, potentially making its platform more valuable to both lenders and borrowers. Next, we’ll examine how embedding Matic’s home insurance marketplace into nCino’s mortgage platform could influence...

Why Gaming and Leisure Properties Is On Investors’ Radar Gaming and Leisure Properties (GLPI) has drawn attention after a recent stretch of steady share performance, with modest gains over the past month and past 3 months prompting a closer look at its fundamentals. See our latest analysis for Gaming and Leisure Properties. At a share price of US$46.20, Gaming and Leisure Properties has seen steady momentum build, with a 30 day share price return of 2.51% and a 5 year total shareholder return...

Applied Optoelectronics (AAOI) has broken ground on a new 210,000 square foot manufacturing facility in Sugar Land, Texas, and has doubled its planned investment in the site to US$300 million to support data center demand. See our latest analysis for Applied Optoelectronics. The new Sugar Land expansion comes after a sharp run in the share price. The 90 day share price return is 104.94% and the 3 year total shareholder return is very large. This suggests momentum has been strong even after a...

If you are trying to figure out whether CAVA Group's share price lines up with its fundamentals, the valuation story is where things start to get interesting. The stock last closed at US$63.61, with a 7 day return of a 1.5% decline, a 30 day return of a 7.2% decline, a year to date return of 5.1% and a 1 year return of a 51.3% decline, which may catch the eye of investors thinking about potential upside or changing risk. Recent coverage around CAVA Group has mainly focused on its position...

State Street (NYSE:STT) has launched a new actively managed Prime Money Market ETF, targeting investors who want exchange traded access to cash management. The company has also reached a wealth management technology agreement with Mariner, which will use State Street's Charles River platform. Together, these moves expand State Street's product shelf and deepen its role as a technology partner for financial advisors. For you as an investor, this combination of a new Prime Money Market ETF...

Why Praxis Precision Medicines stock is back on investors’ radar Praxis Precision Medicines (PRAX) has drawn fresh attention after multiple analysts expressed confidence in its lead drug candidates, alongside upcoming NDA submissions for ulixacaltamide and relutrigine, both with Breakthrough Therapy Designation. See our latest analysis for Praxis Precision Medicines. The recent 2.98% 1 day share price return and 18.55% 30 day share price return, on top of a 1 year total shareholder return of...

Bank OZK stock snapshot after recent movement Bank OZK (OZK) shares recently closed at $48.88. The 1 day and 7 day returns are slightly negative, while the stock shows gains over the past month, past 3 months and year to date. See our latest analysis for Bank OZK. The recent 1 day share price return of 0.75% and 7 day share price return of 2.02% follow stronger gains, with a 30 day share price return of 5.10% and a 90 day share price return of 10.84%. However, the 1 year total shareholder...

Bristol-Myers Squibb (NYSE:BMY) reported strong fourth quarter earnings, supported by a growth portfolio that includes several products now generating more than $1b in annual sales. The company highlighted upcoming pivotal pipeline readouts that could influence its future product mix and long term revenue profile. Bristol-Myers Squibb announced recent business moves, including the acquisition of Orbital Therapeutics, a collaboration with BioNTech, and plans for a new research facility. These...

If you are wondering whether Synchrony Financial's current share price reflects its true worth, you are not alone. This article is built to help you size that up. The stock closed at US$71.11, with returns of a 3.9% decline over 7 days, an 8.9% decline over 30 days, a 16.0% decline year to date, but a 13.0% gain over 1 year, 113.4% over 3 years and 117.1% over 5 years. Recent price moves sit against a backdrop of ongoing focus on consumer credit trends, funding costs and card spending...

Bitdeer Technologies Group (NasdaqCM:BTDR) just posted its FY 2025 third quarter numbers with revenue of US$169.7 million, a basic EPS loss of US$1.28 per share and net income loss of US$266.7 million, putting profitability firmly in focus for investors. The company has seen quarterly revenue move from US$70.1 million in Q1 2025 and US$155.6 million in Q2 2025 to US$169.7 million in Q3. Over the same period, EPS moved from a profit of US$2.15 in Q1 to losses of US$0.76 and US$1.28 in Q2 and...

Global Partners LP recently declared a cash distribution of US$0.7600 per unit (US$3.04 on an annualized basis) for the October–December 2025 period, payable on February 13, 2026 to unitholders of record as of February 9, 2026, and scheduled its fourth-quarter and full-year 2025 results release for February 27, 2026. This distribution decision, coming just ahead of the upcoming earnings release, highlights management’s current capital return priorities and income profile for...

Tidewater recently issued 2026 revenue guidance of US$1.32 billion to US$1.37 billion, reaffirmed vessel utilization near 76%, and left about US$500 million remaining under its share repurchase authorization, while Sagil Capital fully exited its position in the stock. At the same time, Black Bear Value Fund reiterated Tidewater as a key holding, highlighting the company’s sizeable offshore support vessel fleet, reduced debt, and capital return plans as reasons for its continued interest...

IQVIA Holdings (NYSE:IQV) has entered a collaboration with the Duke Clinical Research Institute to advance clinical research in obesity and cardiometabolic trials. The partnership focuses on complex clinical programs and aims to broaden access to diverse patient groups in areas of rising healthcare focus. For investors watching IQVIA Holdings at a share price of $168.85, this new collaboration sits against a backdrop of weak recent returns. The stock has declined 6.7% over the past week,...

MoonStone Phase 2 data and why it matters for Zenas BioPharma (ZBIO) Zenas BioPharma (ZBIO) is in the spotlight after presenting Phase 2 MoonStone trial results for obexelimab in relapsing multiple sclerosis. The drug met its primary endpoint with a highly statistically significant reduction in new active brain lesions. For investors watching ZBIO, the detailed 24 week dataset, together with the late breaking presentation at the ACTRIMS Forum 2026, raises fresh questions about how this...

Safehold (NYSE:SAFE) received an S&P credit rating upgrade to A- with a stable outlook. The company announced a share buyback program alongside plans to monetize more of its unrealized capital appreciation, known as "Carats." Management outlined an expansion of ground lease originations, including a focus on affordable housing and broader geographic reach. Safehold, trading at $14.84, is working to reposition itself in the eyes of both credit markets and equity investors. The stock is up...